Current Report Filing (8-k)
September 13 2017 - 07:07AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 13, 2017
APPLIED GENETIC TECHNOLOGIES CORPORATION
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
Delaware
|
|
001-36370
|
|
59-3553710
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification Number)
|
14193 NW 119
th
Terrace
Suite 10
Alachua,
Florida, 32165
(Address of principal executive offices) (Zip Code)
(386)
462-2204
(Registrants telephone number, including area code)
Not Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check the appropriate box below
if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below).
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company ☒
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☒
Item 2.02.
|
Results of Operations and Financial Condition
|
On September 13, 2017, Applied
Genetic Technologies Corporation issued a press release entitled AGTC Announces Financial Results and Business Update for the Quarter and Fiscal Year Ended June 30, 2017. The press release is furnished as Exhibit 99.1.
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|
|
|
APPLIED GENETIC TECHNOLOGIES CORPORATION
|
|
|
By:
|
|
/s/ William A. Sullivan
|
|
|
William A. Sullivan
|
|
|
Chief Financial Officer
|
Date: September 13, 2017
3
Exhibit Index
|
|
|
Exhibit
No.
|
|
Description
|
|
|
99.1
|
|
Press release dated September 13, 2017, entitled AGTC Announces Financial Results and Business Update for the Quarter and Fiscal Year Ended June 30, 2017
|
Applied Genetic Technolo... (NASDAQ:AGTC)
Historical Stock Chart
From Feb 2024 to Mar 2024
Applied Genetic Technolo... (NASDAQ:AGTC)
Historical Stock Chart
From Mar 2023 to Mar 2024